 |
 |
January
14, 2007 |
 |
|
 |
Volume
VIII, Issue 4 |
 |
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Comments
in the BLOG |
 |
This past Friday Bad Toys announced
it planned to go x-dividend on January 31st. The stock surged another 30%
to close at $1.17, a new multi month high. If you own BTYH
on January 31st, you will get the dividend. If you don't own it on that
date, you won't get it. On February 1, BTYH will open and trade
without the dividend. I have written an extensive BLOG on what it
all means. Please read if you have an interest in this stock.
To use the BLOG, simply go
to the home page at www.otcjournal.com
- the BLOG will scroll down automatically on the upper right side
of your screen. The most current journal entries appear in the lower right
column of your screen in chronological order. Check back frequently for
updates particularly when stocks are moving to overbought or oversold levels
in volatile markets.
 |
Titan Global
(OTC BB: TTGL): Remember CPNE at $.50? |
|
Titan Global was out with
news post close on Friday, and this stock is shaping up to be a big win
for OTC Journal members. I first covered this at the end of October
at $.84. If you jumped in at that level, you are now sitting on
a cool 44% return. Not bad for about 10 weeks.
After close on Friday the company
disclosed its telecom division generated $11 million in revenues
in December. Forget about the month over month comparisons- what I liked-
it was a 28% jump over November. That's impressive. To the
stock market- numbers can be sexy.
Here's the main issue with TTGL.
The company claims it will deliver $140 million in revenues in fiscal
2007, and deliver better than $15 million in profits. Since
they have never been in those lofty levels, and they have consistently
generated losses, the market is still from Missouri- the "SHOW
ME" state.
News like Friday's provides evidence
to support their claims. So, if they can deliver, what is the stock worth?
Here's the math. $140 million in revs and $15 to $20 million
in profits equates to somewhere in the $.275 to $.40 range
in EPS allowing for some non cash charges. With 40 million I&O,
despite the 44% price increase from when I first brought this one to your
attention, the market still only believes this company is worth about $48
million- it's absurd if they deliver the numbers.
Anybody remember CPNE's June
'06 quarterly earnings release? The stock was trading at $.50 in early
August. Within a couple of days post news, the stock was $.75- then
in powered up to a high of $1.80 by mid October.
TTGL is acting like and feels
to me just like CPNE from August to October. The stock had started
behaving a bit better over the summer, and as soon as hard numbers were
reported, off we went.
If you were one of those investors
who jumped into CPNE at $.50, and sold it for a cool 50% profit
at $.75, here's your next opportunity for a big win.
TTGL's fiscal Q1 will be out
next week. This is just the beginning. I am sticking with my price target
of $3. Just on the numbers alone, you need to own this stock now
if you want to relive the CPNE adventure. I love this one right
up to $2 for now, with possible upside adjustments if the company
delivers beyond expectations.
|
 |
Subscribe |
 |
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
|
|
|
|
| The OTCjournal.com Newsletter is
an independent electronic publication committed to providing our readers
with factual information on selected publicly traded companies. All
companies are chosen on the basis of certain financial analysis and other
pertinent criteria with a view toward maximizing the upside potential
for investors while minimizing the downside risk, whenever possible.
Moreover, as detailed below, this publication accepts compensation from
certain of the companies which it features. Likewise, this newsletter
is owned by MarketByte, LLC. To the degrees enumerated herein,
this newsletter should not be regarded as an independent publication.
Go
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclaimer.html
for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html
for Trading Alerts. MarketByte LLC has been paid a fee of $50,000
cash by Titan General for coverage of the company. In addition, MarketByte
LLC has been pledged a fee of 90,000 warrants convertible at $1 and 90,000
warrants convertible at $1.50 into restricted shares by Trilogy Capital
for coverage of the company.
All statements and expressions are
the sole opinions of the editors and are subject to change without notice.
A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities
mentioned. While we believe all sources of information to be factual and
reliable, in no way do we represent or guarantee the accuracy thereof,
nor the statements made herein.
From time to time MarketByte LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services as previously disclosed, and not for investment purposes, the
editors do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of interest
by shareholders or prospective shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are forbidden by company policy to own, buy, sell or otherwise
trade stock for their own benefit in the companies who appear in the publication
unless specifically disclosed in the newsletter. Some of the companies
featured in the OTC Journal pay a cash ESP fee to an affiliated technology
company ranging from $2,000 to $5,000 per month for internet related technology
services.
The Trustee of the MarketByte LLC
Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested
approximately The Trustee of the MarketByte LLC Defined Benefit and Trust
(“the MarketByte Pension Plan”) has invested approximately $310,0000 in
the Longview Fund (“the Longview Limited Partnership”), a limited partnership
in which the MarketByte Pension Plan is a limited partner. No one associated
with the MarketByte Pension Plan has any knowledge, information, or control
as to any past, present, or future investment activities of the Longview
Fund. Longview ocassoinally refers companies to MarketByte LLC for
possible coverage by one of the MarketByte LLC publications, which publications
include The OTCJournal.com Newsletter. Longview may or may not own shares
in the companies that it so refers to MarketByte. MarketByte has no information
(outside of information readily accessible to the general public such as
SEC filings) as to whether Longview owns any shares in the companies that
it refers to MarketByte LLC. The above relationships should be viewed
as a potential and/or actual conflict of interest by shareholders and prospective
shareholders of MarketByte LLC client companies.
The profiles, critiques, and other
editorial content of the OTCjournal.com may contain statements that appear
foward relating to the expected capabilities of the companies mentioned
herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE
OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT
LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY
WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID:$subst('Recip.userid') Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site. MarketByte LLC's mailing
address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.
You
can unsubscribe from this list at any time by Clicking
Here and HITTING SEND. If you are having difficulty removing
yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.
|